B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy

被引：2
|
作者：
Tian, Xinyu [1 ,2 ]
Zheng, Xiangyun [1 ,2 ]
Tian, Dong [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Thorac Oncol, Lung Transplant Res Lab, 37 Guoxue Alley, Chengdu 610041, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2023年 / 8卷 / 01期
关键词：
D O I：
10.1038/s41392-023-01643-w
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The tumour glyco-code as a novel immune checkpoint for immunotherapy
    Ernesto RodrÍguez
    Sjoerd T. T. Schetters
    Yvette van Kooyk
    Nature Reviews Immunology, 2018, 18 : 204 - 211
  • [32] The tumour glyco-code as a novel immune checkpoint for immunotherapy
    Rodriguez, Ernesto
    Schetters, Sjoerd T. T.
    van Kooyk, Yvette
    NATURE REVIEWS IMMUNOLOGY, 2018, 18 (03) : 204 - 211
  • [33] Suppression of TIM-1 predicates clinical efficacy of sublingual immunotherapy for allergic rhinitis in children
    Lin, Zhibin
    Zhou, Lifeng
    Luo, Xi
    Xia, Wentong
    Chen, Dehua
    Xu, Rui
    Wang, Jie
    Luo, Renzhong
    Xu, Geng
    Li, Huabin
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2013, 77 (08) : 1345 - 1349
  • [34] Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice
    Xiao, Sheng
    Brooks, Craig R.
    Zhu, Chen
    Wu, Chuan
    Sweere, Johanna M.
    Petecka, Sonia
    Yeste, Ada
    Quintana, Francisco J.
    Ichimura, Takaharu
    Sobel, Raymond A.
    Bonventre, Joseph V.
    Kuchroo, Vijay K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (30) : 12105 - 12110
  • [35] PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
    Goodman, Aaron
    Patel, Sandip P.
    Kurzrock, Razelle
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (04) : 203 - 220
  • [36] Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity
    Ramsay, Alan G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (03) : 313 - 325
  • [37] TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS AND THE BREAK OF B-CELL TOLERANCE TO AUTOANTIGENS
    de Moel, E. G.
    Rozeman, L.
    Grummels, A.
    Verdegaal, E. M. E.
    Bakker, J. A.
    Kapiteijn, E. H.
    Huizinga, T. W. J.
    Haanen, J. B.
    Toes, R. E. M.
    van der Woude, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 240 - 240
  • [38] Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer
    Kong, Xiaoxiao
    Fu, Meili
    Niu, Xing
    Jiang, Hongxing
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Are normally expressed B-cell differentiation antigens possible target antigens for cellular immunotherapy in B-cell malignancies?
    Grube, M
    Rezvani, K
    Sconocchia, G
    Fujiwara, H
    Melenhorst, JJ
    Hensel, N
    Barrett, AJ
    BLOOD, 2002, 100 (11) : 354A - 355A
  • [40] Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes
    Liu, Yikai
    Chen, Zhiying
    Qiu, Junlin
    Chen, Hongzhi
    Zhou, Zhiguang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345